Skip to main content
. 2021 May 24;8:588375. doi: 10.3389/fmed.2021.588375

Table 1.

Time and events table.

Required measures Screening/ trial entry Visceral debranching as soon as possible after trial entry During neoadjuvant chemotherapy intended start date 2 to 3 weeks after debranching Tumor resection intended date of operation 4–6 weeks after end of chemotherapy Follow-up 0–36 months after tumor resection
Verification of inclusion and exclusion criteria
Informed consent
CT/MRI
Between end of chemotherapy and resection
Ascertainment of data as detailed in “evaluation and follow-up”
Ascertainment of primary endpoint
Start of neoadjuvant chemotherapy
Follow-up exams at the discretion of the treating physician (including Ca 19-9 measurements and cross-sectional imaging as indicated)
Surgery

Measures to be performed at the time points marked with ♦